#EU or "our values" or #regulatory_capture: a study commissioned by the Panel for the Future of Science and Technology
of the EU Parliament on "Improving access to medicines while promoting pharmaceutical innovation" has been withdrawn from the STOA website because of its conclusions, which can still be seen in its surviving presentation slides (https://www.europarl.europa.eu/cmsdata/276822/Study%20presentation%20slides.pdf): "Industry R&D priorities only partially aligned with public health objectives" Source: https://www.ilfattoquotidiano.it/in-edicola/articoli/2023/11/01/big-pharma-la-ue-nasconde-il-dossier-su-prezzi-e-brevetti/ #BigPharma
of the EU Parliament on "Improving access to medicines while promoting pharmaceutical innovation" has been withdrawn from the STOA website because of its conclusions, which can still be seen in its surviving presentation slides (https://www.europarl.europa.eu/cmsdata/276822/Study%20presentation%20slides.pdf): "Industry R&D priorities only partially aligned with public health objectives" Source: https://www.ilfattoquotidiano.it/in-edicola/articoli/2023/11/01/big-pharma-la-ue-nasconde-il-dossier-su-prezzi-e-brevetti/ #BigPharma
Big Pharma: la Ue nasconde il dossier su prezzi e brevetti
Ritirato dal Web un rapporto sull’accesso ai medicinali: dice che le priorità dell’industria prevalgono sulla salute pubblicaAlessandro Mantovani (Il Fatto Quotidiano)
macfranc reshared this.